ArticleInternational journal of women's health2025
Comparative Efficacy of Abdominal Aortic ABO (AABO) vs Common Iliac Artery ABO (CIABO) in Cesarean Delivery for Central Placenta Previa with Placenta Accreta: A Retrospective Study.
Article in International journal of women's health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Prophylactic bilateral internal iliac artery balloon occlusion with immediate sheath removal for placenta accreta spectrum.CVIR endovascular · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To compare the safety and efficacy of abdominal aortic balloon occlusion (AABO) and common iliac artery balloon occlusion (CIABO) in cesarean deliveries for central placenta previa with placenta accreta, using a retrospective study design. Methods: We retrospectively analyzed 65 patients with central placenta previa and placenta accreta who underwent cesarean delivery at our hospital between January 2020 and April 2024. Patients were divided into two groups: the observation group (n=35) received AABO, while the control group (n=30) received CIABO. Outcomes compared included intraoperative blood loss, maternal and neonatal outcomes, and other relevant factors. Data were analyzed using SPSS 26.0, with normally distributed quantitative data assessed by Results: The AABO group had significantly reduced balloon placement time, radiation exposure, intraoperative blood loss (mean 800 ± 150 mL vs 1200 ± 180 mL in CIABO; p<0.05), and transfusion volume (mean 400 ± 100 mL vs 600 ± 120 mL in CIABO; p<0.05). The hysterectomy rate was lower in the AABO group (5.7% vs 16.7% in CIABO; p<0.05). No significant differences were observed in postpartum hemorrhage (14.3% vs 13.3%; p>0.05) or neonatal asphyxia (2.9% vs 3.3%; p>0.05). Postoperative coagulation function at 24 hours was better in the AABO group (p<0.05), with no significant difference in postoperative complications (p>0.05). Conclusion: AABO in cesarean deliveries for central placenta previa with placenta accreta reduces intraoperative blood loss and hysterectomy rates without adverse fetal effects, making it a valuable clinical option.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.